CSPC Pharmaceutical Group Dividends and Buybacks
Dividend criteria checks 3/6
CSPC Pharmaceutical Group is a dividend paying company with a current yield of 6.61% that is well covered by earnings.
Key information
6.6%
Dividend yield
0.5%
Buyback Yield
| Total Shareholder Yield | 7.1% |
| Future Dividend Yield | 4.2% |
| Dividend Growth | 17.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | HK$0.320 |
| Payout ratio | 61% |
Recent dividend and buyback updates
Recent updates
Is CSPC Pharmaceutical Group Limited (HKG:1093) Trading At A 48% Discount?
Nov 15
Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly
Oct 16Earnings Not Telling The Story For CSPC Pharmaceutical Group Limited (HKG:1093) After Shares Rise 26%
Sep 30CSPC Pharmaceutical Group Limited (HKG:1093) Investors Are Less Pessimistic Than Expected
Aug 08Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly
Jun 17CSPC Pharmaceutical Group Limited Just Recorded A 20% Revenue Beat: Here's What Analysts Think
May 29CSPC Pharmaceutical Group (HKG:1093) Has Announced A Dividend Of CN¥0.14
May 21CSPC Pharmaceutical Group (HKG:1093) Will Pay A Dividend Of CN¥0.14
Apr 29There's Reason For Concern Over CSPC Pharmaceutical Group Limited's (HKG:1093) Price
Apr 22CSPC Pharmaceutical Group's (HKG:1093) Dividend Will Be CN¥0.14
Apr 01CSPC Pharmaceutical Group Limited (HKG:1093) Shares Could Be 49% Below Their Intrinsic Value Estimate
Jan 22Some Confidence Is Lacking In CSPC Pharmaceutical Group Limited's (HKG:1093) P/E
Jan 04Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 1093's dividend payments have been volatile in the past 10 years.
Growing Dividend: 1093's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| CSPC Pharmaceutical Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (1093) | 6.6% |
| Market Bottom 25% (HK) | 3.2% |
| Market Top 25% (HK) | 8.0% |
| Industry Average (Pharmaceuticals) | 3.7% |
| Analyst forecast (1093) (up to 3 years) | 4.2% |
Notable Dividend: 1093's dividend (6.61%) is higher than the bottom 25% of dividend payers in the Hong Kong market (3.23%).
High Dividend: 1093's dividend (6.61%) is low compared to the top 25% of dividend payers in the Hong Kong market (8%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (61.4%), 1093's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (129%), 1093's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 00:30 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CSPC Pharmaceutical Group Limited is covered by 49 analysts. 28 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wai Chak Yuen | BOCI Research Ltd. |
| Sharon Shi | BOCI Research Ltd. |
| Ethan Cui | BofA Global Research |